| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.7 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |